Jackson Square Partners’s Evolent Health EVH Stock Holding History

Jackson Square Partners’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-40,593	Closed	-$510K	–	83
2019 Q1	$510K	Hold	40,593	–	–	﹤0.01%	82
2018 Q4	$809K	Hold	40,593	–	–	0.01%	82
2018 Q3	$1.15M	Hold	40,593	–	–	0.01%	82
2018 Q2	$854K	Sell	40,593 -2,836	-7%	-$53.7K	﹤0.01%	86
2018 Q1	$618K	Hold	43,429	–	–	﹤0.01%	85
2017 Q4	$534K	Buy	+43,429	New	+$612K	﹤0.01%	88

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Jackson Square Partners's EVH Position: Q2 2019 in Review

Jackson Square Partners sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 40,593 shares — an estimated $510K sold.

Jackson Square Partners first reported a position in EVH in Q4 2017 and held it in 6 quarters. The position peaked at $1.15M in Q3 2018. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

Jackson Square Partners reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
Jackson Square Partners sold 40,593 Evolent Health shares in Q2 2019, an estimated $510K.
Jackson Square Partners first reported a position in Evolent Health in Q4 2017 and held it in 6 quarters.
Jackson Square Partners's Evolent Health position peaked at $1.15M in Q3 2018.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Jackson Square Partners's 13F filing for Q2 2019, filed 14 Aug 2019.